North American Cardiovascular Monitoring & Diagnostic Devices Market

North American Cardiovascular Monitoring & Diagnostic Devices Market Size (2022 to 2027)

The Cardiovascular Diagnostic and Monitoring Devices Market in North America was worth USD 878.11 million in 2022 and estimated to be growing at a CAGR of 6.53% to reach USD 1204.78 million by 2027.

Cardiovascular disease is a medical condition that affects the structure and function of organs associated with the heart's function and its circulation.

Cardio Vascular diseases are the primary cause of death and witnessing a high rise in prevalence. A large number of people are being diagnosed with cardiovascular diseases such as periphery artery diseases, coronary artery diseases, congenital heart diseases, and pulmonary conditions, shifting focus towards preventative healthcare.

North America's market for cardiovascular devices is majorly driven by an increasing number of people suffering from diabetes and obesity and growing risks related to hypertension and heart muscle weakening. Advancements in Technology have enabled portability features such as portability in performing various tests and adding to the growth of the Cardiovascular Monitoring market. However, unclear reimbursement policies, stringent government regulations for product approvals, and the high cost of devices are major factors restraining market growth.

This research report on the North American Cardiovascular Monitoring & Diagnostic Devices Market has been segmented and sub-segmented into the following categories:

By Product:

• ECG Systems
  • Resting ECG Systems
  • Stress ECG Systems
• Event Monitors
• Holter Monitors
• Implantable Loop Recorders
• ECG Management Systems

Based on product type, ECG systems hold the largest share in the market. They are expected to maintain it’s strong in the market during the forecast period due to widespread availability and increasing preference for diagnostic devices in developed and developing regions.

By Country: 

• The United States
• Canada
• Rest of North America

Based on geography, Within North America, the United States is the largest market for cardiovascular diagnostic and monitoring devices. It is expected to sustain its strong share due to its high awareness about available diagnosis and treatment methods among patients and physicians.

Key participants in the North American Cardiovascular Monitoring & Diagnostic Devices Market profiled in the report are GE Healthcare and Phillips Healthcare, Siemens Healthcare, Boston Scientific Corporation, St. Jude Medical, Inc., Nihon Kohden Corporation, and Welch Allyn, Inc.